Investing.com - Sensei Biotherapeutics reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that was in line with expectations.
Sensei Biotherapeutics announced earnings per share of $-0.44 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.40 on revenue of $0.
Sensei Biotherapeutics shares are down 41.36% from the beginning of the year, still down 86.24% from its 52 week high of $10.10 set on November 15, 2021.
Sensei Biotherapeutics shares lost 0.71% in intra-day trade following the report.
Sensei Biotherapeutics follows other major Healthcare sector earnings this month
Sensei Biotherapeutics's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar